Effectiveness of Oral Sucrose During Lung Ultrasound

Launched by MOUNT SINAI HOSPITAL, CANADA · Jan 30, 2023

Keywords

ClinConnect Summary

This clinical trial is studying whether giving oral sucrose (a type of sugar) can help reduce agitation in preterm infants during a lung ultrasound (a test that uses sound waves to create images of the lungs). The trial compares two groups: one group will receive oral sucrose along with a soother (like a pacifier), while the other group will only receive the soother. The researchers are looking at how calm the infants are during the ultrasound and if there are any complications, like changes in heart rate or breathing.

To participate in this study, infants must be preterm (born before 37 weeks of pregnancy) and currently admitted to the neonatal intensive care unit at Mount Sinai Hospital for a lung ultrasound. They should be stable and not need any special support for their heart or circulatory system. Parents will need to provide written consent for their infants to take part. If an infant has certain medical conditions or is already on pain medications, they won't be eligible to join. This trial is important because it aims to find safe ways to help manage pain and discomfort in vulnerable newborns.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: Patient must meet all inclusion criteria to be eligible for participation that include;
• • Preterm infants (GA \< 37 weeks) admitted to the neonatal intensive care unit, Mount Sinai Hospital,
• • Undergoing LUS for clinical or research purpose,
• • Hemodynamically stable (not requiring any circulatory support), and
• • Written informed parental consent is obtained.
• Exclusion Criteria:
• • Infants with neurological disorders, congenital anomalies that interfere with oral intake,
• • On pain medications, or
• • receiving nothing per oral because of medical condition e.g. necrotizing enterocolitis are excluded